Suppr超能文献

在内分泌治疗前及治疗期间,通过针吸获取的乳腺癌细胞中3H-胸腺嘧啶核苷的掺入情况。

3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.

作者信息

Nordenskjöld B, Löwhagen T, Westerberg H, Zajicek J

出版信息

Acta Cytol. 1976 Mar-Apr;20(2):137-43.

PMID:1065173
Abstract

3H-thymidine autoradiography was used to evaluate DNA-synthesis in carcinoma cells obtained by fine-needle aspiration biopsy from mammary carcinomas. Needle aspirates were analyzed before and after oophorectomy, and before and during treatment with oestrogen or anti-oestrogen (tamoxifen). Tumor regression occurred in 18 patients-in one of four following oophorectomy, in 15 of 38 treated with tamoxifen and in two of three given oestrogen. Seven tumors remained stationary for long periods-up to a year. In 20 cases there was tumor progression. Regression of tumors was preceded by a decrease in the fraction of 3H-thymidine-labeled cells (s-phase cells). The tumors that remained stationary or progressed retained significant levels of 3H-thymidine incorporation. This study thus showed that 3H-thymidine autoradiography can give an early estimate of tumour response to endocrine therapy. Considerable differences were found between the carcinomas in regard to proportions of S-phase cells. Further insight into this parameter may be useful for planning chemotherapy with S-phase specific agents.

摘要

采用³H-胸腺嘧啶核苷放射自显影术评估通过乳腺细针穿刺活检获取的癌细胞中的DNA合成。在卵巢切除术前和术后,以及在雌激素或抗雌激素(他莫昔芬)治疗前和治疗期间,对针吸细胞进行分析。18例患者出现肿瘤消退——卵巢切除术后4例中有1例,他莫昔芬治疗的38例中有15例,给予雌激素治疗的3例中有2例。7个肿瘤长期保持稳定——长达一年。20例出现肿瘤进展。肿瘤消退之前,³H-胸腺嘧啶核苷标记细胞(S期细胞)比例下降。保持稳定或进展的肿瘤保留了显著水平的³H-胸腺嘧啶核苷掺入。因此,本研究表明³H-胸腺嘧啶核苷放射自显影术可对肿瘤对内分泌治疗的反应做出早期评估。在S期细胞比例方面,癌之间存在相当大的差异。进一步深入了解该参数可能有助于规划使用S期特异性药物的化疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验